<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04422197</url>
  </required_header>
  <id_info>
    <org_study_id>R.19.05.515</org_study_id>
    <nct_id>NCT04422197</nct_id>
  </id_info>
  <brief_title>This Randomized Controlled Study Aims to Investigate the Effect of Botox Injection in Abdominal Wall Muscle Post Major Abdominal Surgery in Terms of Postoperative Pain, Incidence of Incisional Hernia.</brief_title>
  <official_title>Effect of Botox Injection on Lateral Abdominal Wall Muscles After Major Open Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the work This randomized controlled study aims to investigate the effect of botox
      injection in abdominal wall muscle post major abdominal surgery in terms of postoperative
      pain, incidence of incisional hernia Study design and setting This is a double-blind
      prospective randomized controlled trial that will be conducted in the general surgery
      department and colorectal surgery unit of Mansoura University hospital in the period from
      June 2019 to June2020. The patient's recruitment process will be started and continued for
      one year after getting the approval from the local Institutional Review Board in Mansoura
      University in concordance with the Helsinki Declaration Principals. The data will be
      collected and analyzed prospectively. A signed informed consent will be obtained from every
      patient before enrollment highlighting the possible future publication. On request, patients
      can be excluded from the study at any time if they do not want to continue.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2020</start_date>
  <completion_date type="Anticipated">December 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of incisional hernia.</measure>
    <time_frame>one year</time_frame>
    <description>incidence of incisional hernia.Effect of Botox injection on lateral abdominal wall muscles after major open abdominal surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hernia, Abdominal</condition>
  <arm_group>
    <arm_group_label>Patients with ultrasound-guided botox injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Effect of Botox injection on lateral abdominal wall muscles after major open abdominal surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with no botox injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with major abdominal surgery without botox injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Botox</intervention_name>
    <description>effect of botox injection in abdominal wall muscle post major abdominal surgery in terms of postoperative pain, incidence of incisional hernia.</description>
    <arm_group_label>Patients with ultrasound-guided botox injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery without botox injection</intervention_name>
    <description>surgery without botox injection</description>
    <arm_group_label>Patients with no botox injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Patients with major abdominal surgery including trauma and elective exploration surgery,
        damage control surgery.

        Exclusion Criteria:

          -  pregnancy

          -  patients with myopathies

          -  motor polyneuropathies, impaired neuromuscular transmission (Myasthenia Gravis)

          -  complicated Chronic Obstructive Pulmonary Disease (COPD),

          -  necrotizing fasciitis of the trunk

          -  unfit for general anesthesia

          -  patients with psychiatric disorders

          -  patients with drug abuse or history of opioid intake

          -  chronic pain disorder

          -  coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed Arnouse</last_name>
    <phone>01099222561</phone>
    <email>drmhamdy@mans.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahmoud Abdelnaby</last_name>
    <phone>01099222561</phone>
    <email>Abdelshafymahmoud@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Hamada Mohamed Hamada</last_name>
      <phone>+20 109 212 7930</phone>
      <email>irb.mfm@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 3, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Abdominal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

